Plasma IDO activity was not altered (P = 0.9324) in a subset of ccRCC subjects (n = 37) by obesity status, suggesting that the IDO1 alteration is specific to the tumor microenvironment (Fig 5C). Here, IDO1 is linked to obesity due to melanocortin 4 receptor deficiency.